125) y criteria and were included in the final analysis. |
126) y criteria and were included in the final analysis. |
127) icant predictors for BCR in multivariable analysis. |
128) hecking identified further literature for analysis. |
129) wever, only 26 were selected in the final analysis. |
130) luded feedback into both study design and analysis. |
131) e eligibility criteria were retrieved for analysis. |
132) ted secondary data were excluded from the analysis. |
133) ormed using Cox proportional hazard ratio analysis. |
134) erials were characterized by FTIR and SEM analysis. |
135) adjusted for c.169C>T in multivariate analysis. |
136) and objectivity to two-dimensional image analysis. |
137) rther limited by the lack of multivariate analysis. |
138) udinal studies mainly were secondary data analysis. |
139) ture sources identified 118 documents for analysis. |
140) UV-Vis spectroscopy and thermogravimetric analysis. |
141) criptive statistical methods and thematic analysis. |
142) method for conducting reflexive thematic analysis. |
143) l of 13 articles included in the thematic analysis. |
144) hen subjected to descriptive and thematic analysis. |
145) etween sample collection and ground-based analysis. |
146) eneration of scRNA library and sequencing analysis. |
147) in schizophrenia and required an in-depth analysis. |
148) ly, followed by annotation and expression analysis. |
149) conducted multi-omics integration network analysis. |
150) d subjected to microarray gene expression analysis. |
151) ent of outcomes measures, and statistical analysis. |
152) ping review that yielded 193 articles for analysis. |
153) sing chromatin immunoprecipitation (ChIP) analysis. |
154) n criteria to select articles for further analysis. |
155) ases, identifying 17 clinical studies for analysis. |
156) e region (0.20 to 0.82) with network meta-analysis. |
157) istic regression for each cohort and meta-analysis. |
|